Antimicrobial agents for systemic administration. Macrolides. ATC code J01F А09.

Indications to Use:

Treatment of infections caused by microorganisms sensitive to clarithromycin:

• low respiratory tract infections (bronchitis, acute croupous pneumonia and primary atypical pneumonia)

• upper respiratory tract infections, that is of the nasopharynx (pharyngitis, tonsillitis), and infections of the paranasal sinuses;

• infections of the skin and soft tissues (impetigo, folliculitis, erysipeloid, furunculosis, infected wounds)

• disseminated or localized mycobacterial infections caused by Mycobacterium avium or Mycobacterium intracellulare. Localized infections caused by Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kansasii;

• eradication of Helicobacter pylori in patients with duodenal ulcer in inhibiting of secretion of hydrochloric acid (activity of clarithromycin against H. pylori at a neutral pH is higher than at an acid pH)

• acute and chronic odontogenic infections.